Commercialisation Of Biosimilars: Strategies For Market Penetration

Based on expert opinions from the top commentators in the field, the report offers insight into how European biosimilar markets have evolved. It also includes up to the minute US case studies, insight into specific approaches to biosimilars intended for multiple diseases and which strategies have proven most effective-and why. Learn more here. (Source: FirstWord, 11/2013).

You might also be interested in:

What Are The Recent Top 4 Innovative Consolidations and… 08/26/2020
ICER Signs Multi-Year Deal to Use New Cloud-Based Analytic… 02/20/2020
Association for Accessible Medicines (AAM) Names Health Care… 08/25/2020
Using AI, NLP and Data Visualization with RWE to Generate… 06/10/2020
Tufts Analyzes Cost-Effectiveness Analysis for 1974-2018 07/28/2020
PRMA Consulting Announces New Singapore Office and Virtual Open House 08/11/2020
Scientist.com to Acquire HealthEconomics.Com, the World’s… 12/15/2020